Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mckenzie DiLeo

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Dermatology Online Journal|June 17, 2025
A unique presentation of diffuse multiple eruptive miliaMckenzie DiLeo, Reece Moore, Emelie E Nelson, et al.
Cureus|July 21, 2023
An Atypical Migration Pattern of Tattoo PigmentEmily M Cao, Mckenzie DiLeo, Emelie E Nelson, et al.
Cancer|January 21, 2026
Retrospective analysis of cutaneous immune-related adverse events following checkpoint inhibitor therapy in melanoma patients reveals increased risk associated with the HLA-B*51:01 alleleMckenzie DiLeo, Samantha Oglesby, Cheuk Hong Leung, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Dermatology Online Journal|June 17, 2025
A unique presentation of diffuse multiple eruptive miliaMckenzie DiLeo, Reece Moore, Emelie E Nelson, et al.
Cureus|July 21, 2023
An Atypical Migration Pattern of Tattoo PigmentEmily M Cao, Mckenzie DiLeo, Emelie E Nelson, et al.
Cancer|January 21, 2026
Retrospective analysis of cutaneous immune-related adverse events following checkpoint inhibitor therapy in melanoma patients reveals increased risk associated with the HLA-B*51:01 alleleMckenzie DiLeo, Samantha Oglesby, Cheuk Hong Leung, et al.
Pageof 1